Search Results

You are looking at 71 - 80 of 384 items for :

  • "early detection" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

QIM20-126: Prehabilitation Model of Care for the Patient with Breast Cancer

Karen Hock and Cari Utendorf

Background: Breast cancer related lymphedema (BCRL) is a progressive, morbid, and incurable disease with an incidence rate of 6-47%. (Soran 2016) Early detection models have been discussed since 2013, but very few (if any programs) existed at this

Full access

Targeted Therapy in the Macro Mode

Rodger J. Winn

and initial breast cancer treatment . J Natl Cancer Inst 2001 ; 93: 1344 – 1346 . 4 Liu M Hawk H Gershman ST . The effects of a National Breast and Cervical Cancer Early Detection Program on social disparities in breast cancer

Full access

QIM22-207: Physical Therapy Assessment for Management of Breast Cancer Related Lymphedema After Axillary Lymph Node Dissection

Kevin Zhang, Ladan Navari, Amy Li, Sandy Lee, Yevgeniya Gokun, Min-Jeong Cho, Roman Skoracki, and Ko Un Park

lymphedema specialist for baseline limb measurements of both sides prior to surgery and early detection of lymphedema for optimal management. The goal of this study is to evaluate the rate of physical therapy (PT) assessment after ALND. Methods : Under IRB

Full access

EPR24-104: Re-Evaluating Breast Cancer Screening Recommendations: An Analysis of Breast Cancer Incidence by Age Groups

Jerry Kenmoe, Calvin Ghimire, Harneet Ghumman, Jores Kenmoe, Tejaswi Vinjam, and Arvind Kunadi

early detection strategies. Methods: We used Incidence-SEER Research Plus Limited-Field Data, 22 Registries, Nov 2021 Sub (2000–2019) and extracted Incidence rates for females with breast cancer by age groups (20–24, 25–29, 30–34, 35–39, 40–44, 45

Full access

HSR21-066: A Retrospective Analysis of Tumor Recurrence of Locally Advanced Cervical Cancer in a Tertiary Government Hospital

Martha Isabel Junio Parroco and Genalin Fabul Amparo

the improvement of early detection of recurrent disease leading to longer over-all survival since recurrent cervical cancer has always been established to be of poor prognosis. The subjects were identified from a single government institution. A

Full access

Reflecting the Debates of Updating the Prostate Cancer Guidelines

James L. Mohler

The ideas and viewpoints expressed in this editorial are those of the author and do not necessarily represent any policy, position, or program of the NCCN. References 1. Howard D H . Life expectancy and the value of early

Full access

Toward Precision Pancreatic Cancer Care

Robert Goldberg

Unlike in many other tumor types, in pancreatic cancer, patients and physicians lack reliable and accessible tools for early detection in the primary care setting. 1 In the absence of blood- or saliva-based tests, researchers and patient advocacy

Full access

NCCN News

(USPSTF), Barbara A. Levey & Gerald S. Levey Distinguished Professor of Medicine and Public Health, University of California Los Angeles. During the summit, speakers and panelists explored the current landscape for cancer screening and early detection

Full access

Ten Years of Progress in Prostate Cancer

James L. Mohler

-approved 1986) and then for early detection (FDA-approved 1994). The second was the development, by Patrick Walsh and his colleagues at Johns Hopkins Hospital, of anatomic radical prostatectomy that made surgical treatment of clinically localized prostate cancer

Full access

Introducing the New Editor-in-Chief

Margaret Tempero

and saw a meteoric rise in submissions as well as a substantial increase in our impact factor, from 4.237 to 13.4. And as I step aside, don’t worry about what will fill my time. I am taking a sabbatical to create a new Center for Early Detection and